|
Best overall response by criteria. |
||
| Criteria |
Response/Evaluable |
% (95% CI) |
|
|
||
| PSA |
5/22 |
23 (8–45) |
| Measurable |
0/8 |
0 (0–31) |
| Bone disease |
1/20 |
5 (0–25) |
Gross et al. BMC Cancer 2007 7:142 doi:10.1186/1471-2407-7-142 |
||